138 related articles for article (PubMed ID: 10599747)
1. Toward the establishment of a clinical prediction rule for response of prolactinomas to cabergoline.
Delgrange E; Donckier JE
J Clin Endocrinol Metab; 1999 Dec; 84(12):4746-7. PubMed ID: 10599747
[No Abstract] [Full Text] [Related]
2. Toward the establishment of a clinical prediction rule for response of prolactinomas to cabergoline.
Verhelst JA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4747. PubMed ID: 10599748
[No Abstract] [Full Text] [Related]
3. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Delgrange E; Donckier J
J Clin Endocrinol Metab; 1997 Aug; 82(8):2755-6. PubMed ID: 9253367
[No Abstract] [Full Text] [Related]
4. Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
Colao A; Lombardi G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2756. PubMed ID: 9253368
[No Abstract] [Full Text] [Related]
5. Visual vignette. Cabergoline therapy.
Stanciu I; Gordon DL
Endocr Pract; 2003; 9(5):475. PubMed ID: 14583429
[No Abstract] [Full Text] [Related]
6. Cabergoline, a hopeful medicine for prolactinomas and non-tumoral hyperprolactinemia.
Miki N
Intern Med; 2001 Sep; 40(9):845-6. PubMed ID: 11579939
[No Abstract] [Full Text] [Related]
7. [Cabergoline-induced tension pneumocephalus in a patient with giant invasive prolactinoma. Case report].
Castro-Castro J; Torre-Eiriz JA; Pinzón-Millán A; Pastor-Zapata A
Neurocirugia (Astur); 2011 Dec; 22(6):558-61; discussion 561. PubMed ID: 22167286
[TBL] [Abstract][Full Text] [Related]
8. Tumour shrinkage and chiasmal herniation after successful cabergoline treatment for a macroprolactinoma.
Marcos L; De Luis DA; Botella I; Hurtado A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):126-7. PubMed ID: 11167937
[No Abstract] [Full Text] [Related]
9. Cabergoline and quinagolide therapy for prolactinomas.
Webster J
Clin Endocrinol (Oxf); 2000 Nov; 53(5):549-50. PubMed ID: 11106914
[No Abstract] [Full Text] [Related]
10. Giant pubertal prolactinoma: Complete resolution following short term carbegoline treatment.
Oguz A; Tuzun D; Sahin M; Gul K
Niger J Clin Pract; 2016; 19(5):685-7. PubMed ID: 27538562
[TBL] [Abstract][Full Text] [Related]
11. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
[No Abstract] [Full Text] [Related]
12. Pons herniation into skull base after cabergoline therapy of giant prolactinoma.
Moles Herbera J; Rivero Celada D; Montejo Gañan I; Fustero de Miguel D; Fuentes Uliaque C; Vela Marín AC
Pituitary; 2015 Feb; 18(1):68-71. PubMed ID: 24522845
[TBL] [Abstract][Full Text] [Related]
13. Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now?
Christoforidis A; Tsakalides C; Anastasiou A; Pavlaki A; Dimitriadou M
Neuro Endocrinol Lett; 2013; 34(4):275-7. PubMed ID: 23803868
[TBL] [Abstract][Full Text] [Related]
14. Prolactinomas, cabergoline, and pregnancy.
Glezer A; Bronstein MD
Endocrine; 2014 Sep; 47(1):64-9. PubMed ID: 24985062
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of cabergoline in the treatment of macroprolactinoma].
Dupuy O; Le Marec E; Mayaudon H; Rilminger H; Bordier L; Bauduceau B
Presse Med; 2003 Jan; 32(2):71-2. PubMed ID: 12653031
[No Abstract] [Full Text] [Related]
16. A case of postprandial cluster-like headache with prolactinoma: dramatic response to cabergoline.
Negoro K; Kawai M; Tada Y; Ogasawara J; Misumi S; Morimatsu M
Headache; 2005 May; 45(5):604-6. PubMed ID: 15953282
[TBL] [Abstract][Full Text] [Related]
17. [Serum concentrations of glucose, cholesterol and triglycerides in men with prolactinoma treated with cabergoline].
Iglesias P; Villabona C; Díez JJ
Med Clin (Barc); 2016 Nov; 147(10):466-467. PubMed ID: 27452305
[No Abstract] [Full Text] [Related]
18. SUNCT syndrome in a patient with prolactinoma and cabergoline-induced attacks.
Jiménez Caballero PE
Cephalalgia; 2007 Jan; 27(1):76-8. PubMed ID: 17212687
[TBL] [Abstract][Full Text] [Related]
19. Cabergoline resistance in pediatric prolactinomas.
Spinks JJ; Ryan FJ
J Pediatr Hematol Oncol; 2009 May; 31(5):377-9. PubMed ID: 19415025
[TBL] [Abstract][Full Text] [Related]
20. Prolactinomas.
Couldwell WT; Weiss MH; Laws ER
N Engl J Med; 2004 Mar; 350(10):1054-7; author reply 1054-7. PubMed ID: 15002121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
